A detailed history of Cubist Systematic Strategies, LLC transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 89,872 shares of ACET stock, worth $79,986. This represents 0.0% of its overall portfolio holdings.

Number of Shares
89,872
Previous 409,049 78.03%
Holding current value
$79,986
Previous $494,000 73.89%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.07 - $1.63 $341,519 - $520,258
-319,177 Reduced 78.03%
89,872 $129,000
Q2 2024

Aug 14, 2024

BUY
$1.21 - $2.4 $439,344 - $871,428
363,095 Added 790.13%
409,049 $494,000
Q1 2024

May 15, 2024

BUY
$1.76 - $3.45 $46,497 - $91,145
26,419 Added 135.24%
45,954 $107,000
Q4 2023

Feb 14, 2024

SELL
$1.11 - $1.89 $13,553 - $23,076
-12,210 Reduced 38.46%
19,535 $36,000
Q3 2023

Nov 14, 2023

BUY
$1.37 - $3.4 $43,490 - $107,933
31,745 New
31,745 $43,000
Q1 2023

May 15, 2023

BUY
$5.52 - $9.23 $272,881 - $456,285
49,435 New
49,435 $284,000
Q2 2022

Aug 15, 2022

BUY
$10.26 - $20.81 $450,649 - $914,037
43,923 Added 7320.5%
44,523 $650,000
Q1 2022

May 16, 2022

SELL
$11.53 - $19.97 $334,842 - $579,948
-29,041 Reduced 97.98%
600 $12,000
Q4 2021

Feb 14, 2022

BUY
$7.37 - $17.49 $140,170 - $332,642
19,019 Added 179.05%
29,641 $518,000
Q3 2021

Nov 15, 2021

SELL
$6.29 - $9.93 $11,850 - $18,708
-1,884 Reduced 15.06%
10,622 $83,000
Q2 2021

Aug 16, 2021

BUY
$9.19 - $15.93 $114,930 - $199,220
12,506 New
12,506 $129,000

Others Institutions Holding ACET

About Adicet Bio, Inc.


  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $35.6M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.